Skip to main content
SpringerLink
Log in

Association of genetic variants in tachykinins pathway genes with colorectal cancer risk

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

This study aims to explore the associations of polymorphisms in tachykinin, precursor 1 (TAC1), tachykinin receptor 1 (TACR1), and tachykinin receptor 2 (TACR2) genes and their interactions with the risk of colorectal cancer (CRC) among Chinese population.

Methods

A population-based case-control study which included 394 cases and 393 cancer-free controls was carried out. A total of 19 tagSNPs in the three genes were chosen based on HapMap and NCBI datasets and genotyped by SNPshot assay. Multiple logistic regression models were applied to evaluate the associations of SNPs with CRC after adjustment for potential covariates. Furthermore, generalized multifactor dimensionality reduction (GMDR) method was used to test the interactive effect among three genes on CRC.

Results

Compared with those carrying rs3755457 CC/CT or rs12477554 TT/CT genotype, individuals carrying homozygous variants had higher risk of colorectal cancer (adjusted OR = 1.80, 95 % CI = 1.03–3.13, P = 0.039 for rs3755457; adjusted OR = 1.73, 95 % CI = 1.07–2.79, P = 0.024 for rs12477554). As for rs10198644, GG genotype was associated with a 1.72-fold (95 % CI = 0.37–0.88) decreased risk when compared with the common CC genotype. Moreover, the GMDR analysis indicated that the best interactive model included five polymorphisms: rs2072100 (TAC1), rs10198644 (TACR1), rs2193409 (TACR1), rs3771810 (TACR1), and rs4644560 (TACR2).

Conclusions

Our study suggests that tachykinins pathway genes may participate in the development of CRC and the potential interactions among the three genes on CRC may exist, which has to be confirmed in future larger studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  2. Wu M, Zhang SW, Han RQ, Zhou JY, Zou XN, Chen WQ (2010) Analysis on the mortality of colorectal and anal cancer in China during 2004–2005. Zhonghua Yu Fang Yi Xue Za Zhi 44(5):403–407

    PubMed  Google Scholar 

  3. Singh D, Joshi DD, Hameed M, Qian J, Gascon P, Maloof PB, Mosenthal A, Rameshwar P (2000) Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. Proc Natl Acad Sci USA 97(1):388–393

    Article  PubMed  CAS  Google Scholar 

  4. David S, Kan T, Cheng Y, Agarwal R, Jin Z, Mori Y (2009) Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer. Biochem Biophys Res Commun 378(3):605–609

    Article  PubMed  CAS  Google Scholar 

  5. Jin Z, Olaru A, Yang J, Sato F, Cheng Y, Kan T, Mori Y, Mantzur C, Paun B, Hamilton JP, Ito T, Wang S, David S, Agarwal R, Beer DG, Abraham JM, Meltzer SJ (2007) Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer. Clin Cancer Res 13(21):6293–6300

    Article  PubMed  CAS  Google Scholar 

  6. Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc M, Palma C, Zimmermann A, Reubi JC, Buchler MW (2003) Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer. Lab Invest 83(5):731–742

    PubMed  CAS  Google Scholar 

  7. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA (2004) Tachykinins and tachykinin receptors: a growing family. Life Sci 74(12):1445–1463

    Article  PubMed  CAS  Google Scholar 

  8. Patacchini R, Lecci A, Holzer P, Maggi CA (2004) Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci 25(1):1–3

    Article  PubMed  CAS  Google Scholar 

  9. Jaafari N, Hua G, Adelaide J, Jule Y, Imbert J (2008) Expression of the tachykinin receptor mRNAs in healthy human colon. Eur J Pharmacol 599(1–3):121–125

    Article  PubMed  CAS  Google Scholar 

  10. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V (2002) The tachykinin peptide family. Pharmacol Rev 54(2):285–322

    Article  PubMed  CAS  Google Scholar 

  11. Watanabe T, Kubota Y, Muto T (1997) Substance P containing nerve fibers in rectal mucosa of ulcerative colitis. Dis Colon Rectum 40(6):718–725

    Article  PubMed  CAS  Google Scholar 

  12. Vento P, Kiviluoto T, Keranen U, Jarvinen HJ, Kivilaakso E, Soinila S (2001) Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis. J Histochem Cytochem 49(6):749–758

    Article  PubMed  CAS  Google Scholar 

  13. Rosso M, Robles-Frias MJ, Covenas R, Salinas-Martin MV, Munoz M (2008) The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines. Tumour Biol 29(4):245–254

    Article  PubMed  CAS  Google Scholar 

  14. Ogasawara M, Murata J, Ayukawa K, Saiki I (1997) Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Cancer Lett 119(1):125–130

    Article  PubMed  CAS  Google Scholar 

  15. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ (1993) Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 110(1):43–49

    Article  PubMed  CAS  Google Scholar 

  16. Rameshwar P, Gascon P (1996) Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 88(1):98–106

    PubMed  CAS  Google Scholar 

  17. Reeve JG, Bleehen NM (1994) [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro. Biochem Biophys Res Commun 199(3):1313–1319

    Article  PubMed  CAS  Google Scholar 

  18. Fan C, Jin M, Chen K, Zhang Y, Zhang S, Liu B (2007) Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer 7:115

    Article  PubMed  Google Scholar 

  19. Nasiri H, Forouzandeh M, Rasaee MJ, Rahbarizadeh F (2005) Modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal 19(6):229–232

    Article  PubMed  CAS  Google Scholar 

  20. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265

    Article  PubMed  CAS  Google Scholar 

  21. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, Li MD (2007) A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80(6):1125–1137

    Article  PubMed  CAS  Google Scholar 

  22. Hennig IM, Laissue JA, Horisberger U, Reubi JC (1995) Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61(6):786–792

    Article  PubMed  CAS  Google Scholar 

  23. Akazawa T, Kwatra SG, Goldsmith LE, Richardson MD, Cox EA, Sampson JH, Kwatra MM (2009) A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas. J Neurochem 109(4):1079–1086

    Article  PubMed  CAS  Google Scholar 

  24. Munoz M, Rosso M, Aguilar FJ, Gonzalez-Moles MA, Redondo M, Esteban F (2008) NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Invest New Drugs 26(2):111–118

    Article  PubMed  CAS  Google Scholar 

  25. Nowicki M, Miskowiak B (2003) Substance P—a potent risk factor in childhood lymphoblastic leukaemia. Leukemia 17(6):1096–1099

    Article  PubMed  CAS  Google Scholar 

  26. Luo W, Sharif TR, Sharif M (1996) Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res 56(21):4983–4991

    PubMed  CAS  Google Scholar 

  27. Munoz M, Rosso M, Perez A, Covenas R, Rosso R, Zamarriego C, Soult JA, Montero I (2005) Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines. Invest Ophthalmol Vis Sci 46(7):2567–2570

    Article  PubMed  Google Scholar 

  28. Munoz M, Rosso M, Perez A, Covenas R, Rosso R, Zamarriego C, Piruat JI (2005) The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides 39(4):427–432

    Article  PubMed  CAS  Google Scholar 

  29. Palma C (2006) Tachykinins and their receptors in human malignancies. Curr Drug Targets 7(8):1043–1052

    Article  PubMed  CAS  Google Scholar 

  30. Reubi JC (1997) Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy. Q J Nucl Med 41(2):63–70

    PubMed  CAS  Google Scholar 

  31. Reubi JC, Zimmermann A, Jonas S, Waser B, Neuhaus P, Laderach U, Wiedenmann B (1999) Regulatory peptide receptors in human hepatocellular carcinomas. Gut 45(5):766–774

    Article  PubMed  CAS  Google Scholar 

  32. Cunningham S, Patterson CC, McDonnell G, Hawkins S, Vandenbroeck K (2005) Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis. Genes Immun 6(3):265–270

    Article  PubMed  CAS  Google Scholar 

  33. Giegling I, Rujescu D, Mandelli L, Schneider B, Hartmann AM, Schnabel A, Maurer K, De Ronchi D, Moller HJ, Serretti A (2007) Tachykinin receptor 1 variants associated with aggression in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 144B(6):757–761

    Article  PubMed  CAS  Google Scholar 

  34. Renner SP, Ekici AB, Maihofner C, Oppelt P, Thiel FC, Schrauder M, Uenluehan N, Bani MR, Strissel PL, Strick R, Beckmann MW, Fasching PA (2009) Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosis. Gynecol Endocrinol 25(11):726–733

    Article  PubMed  CAS  Google Scholar 

  35. Friedrich P, Feulner TM, Laws SM, Eckart K, Perneczky R, Kurz A, Forstl H, Riemenschneider M (2011) No association of tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease. Neurobiol Aging 32(3):544–545

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The study was funded in part by grants from the New Teacher Foundation of the Ministry of Education (20090101120103), Natural Science Foundation of Zhejiang Province (Y2090154 and Y2110499), Department of Education of Zhejiang Province (Z200804565), and Zhejiang Foundation of Young Teachers' innovation (2009QNA7018). We are grateful to all participants for agreeing to take part in our study. We also thank the staff of Cancer Institute of Jiashan County for their continuous support and assistance to collect the epidemiological data and blood specimen.

Author information

Authors and Affiliations

  1. Department of Epidemiology & Health Statistics, School of Public Health, Zhejiang University, 866 Yu-Hang-Tang Road, Xihu District, Hangzhou, 310058, Zhejiang, China

    Yunxian Yu, Yifeng Pan, Mingjuan Jin, Mingwu Zhang, Shanchun Zhang, Xia Jiang, Hui Liu, Jing Guo, He Liu & Kun Chen

  2. Institute of Cancer Research and Prevention of Jiashan County, Jiashan, Zhejiang, China

    Qilong Li

Authors
  1. Yunxian Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yifeng Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mingjuan Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mingwu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shanchun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qilong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xia Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jing Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. He Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kun Chen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 177 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, Y., Pan, Y., Jin, M. et al. Association of genetic variants in tachykinins pathway genes with colorectal cancer risk. Int J Colorectal Dis 27, 1429–1436 (2012). https://doi.org/10.1007/s00384-012-1478-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-012-1478-7

Keywords

Search

Navigation